Sofyan Amrabat has been called up to the Moroccan squad for their two games against Liberia and Burkina Faso despite the midfielder having a minor back issue.

Amrabat, who completed his loan move to Manchester United last Friday, is included in the squad for the nation’s games in the build-up to the African Cup of Nations.

The 27-year-old midfielder has been nursing a back issue since the last 16 game against Spain in the 2022 World Cup in Qatar and had to receive pain-killing injections to be able to play the game against Luis Enrique’s side.

During the midfielder’s medical, that issue was flagged up but United, according to The Athletic, didn’t believe that the issue was a serious one so they pressed ahead with the deal on the same terms that they had agreed with Fiorentina.

Croatia v Morocco: 3rd Place - FIFA World Cup Qatar 2022
Photo by Visionhaus/Getty Images

Amrabat’s Morocco risk

The midfielder has been nursing an injury so it does seem to be a risk for the former Utrecht man to feature in these games for his national side.

Erik ten Hag will certainly be worrying about the fitness of his newest midfield signing and it may well be a risk for Amrabat to feature in these games.

Unclear if Amrabat will attend

With the injury in mind, and Amrabat’s need to settle in Manchester, it is unclear if the midfielder will join up with the Morocco squad.

United should surely rather he stayed, to rest, and acclimatise to his new surroundings.

United’s injury issues

United have had a plethora of injury issues with the Red Devils suffering a multitude of injury issues with Rasmus Hojlund, the club’s new striker signing, missing the start of the season due to another back issue.

Apart from Hojlund and Amrabat, the injuries suffered by United are surely a cause for concern to Ten Hag.

The pre-season schedule was very compact and it now seems the relentless fixtures during the off-season is catching up with the Red Devils and you would have to question the club’s decision to agree to all of those pre-season games.